MDR-TB
Clinical trials for MDR-TB explained in plain language.
Never miss a new study
Get alerted when new MDR-TB trials appear
Sign up with your email to follow new studies for MDR-TB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
French trial aims to slash tuberculosis treatment time in half
Disease control Not yet recruitingThis study is testing a new, much shorter 6-month drug combination for adults with multidrug-resistant tuberculosis (MDR-TB) in France. It will compare the new regimen's success rate to the results from patients who received older, much longer treatments (often 18+ months). The g…
Matched conditions: MDR-TB
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Breakthrough hope for Drug-Resistant TB: shorter treatment with new pill
Disease control Not yet recruitingThis study is testing whether adding a new drug called acetohydroxamic acid (AHA) to existing shorter treatment regimens can help people with multidrug-resistant tuberculosis. Researchers will enroll 120 participants to see if the combination is safe and effective at clearing the…
Matched conditions: MDR-TB
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC